share_log
Moomoo 24/7 ·  Apr 18 06:30
Cerevel Therapeutics Holdings Inc: Tavapadon Met Primary Endpoint in Pivotal Phase 3 Tempo-3 Adjunctive Trial
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment